Clolar and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clolar (clofarabine) and Furosemide (furosemide). Common drug interactions include hypoxia among females and depressed level of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Clolar and Furosemide. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Clolar?

Clolar has active ingredients of clofarabine. eHealthMe is studying from 1,093 Clolar users. Check the latest studies of Clolar.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

36 people who take Clolar and Furosemide together, and have interactions are studied.

Clolar and Furosemide drug interactions.

What are the common drug interactions of Clolar and Furosemide, by gender? *:

female:

  1. Hypoxia (low oxygen in tissues)
  2. Intervertebral disc protrusion (spinal disc protrusion)
  3. Micturition urgency (urgency to pass the urine)
  4. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  5. Respiratory distress (difficulty in breathing)
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Stem cell transplant
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Acidosis (build-up of carbon dioxide in the blood)
  10. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)

male:

  1. Depressed level of consciousness
  2. Hypotension (abnormally low blood pressure)
  3. Nocardiosis (an infectious disease affecting either the lungs or whole body)
  4. Pleural effusion (water on the lungs)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Small intestinal obstruction (blockage in small intestine)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Adenovirus infection
  9. Bk virus infection
  10. Cardiotoxicity (damage to the heart muscle)

What are the common drug interactions of Clolar and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Depressed level of consciousness
  2. Hypoxia (low oxygen in tissues)
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Adenovirus infection
  5. Bk virus infection
  6. Cytomegalovirus infection
  7. Hypotension (abnormally low blood pressure)
  8. Metapneumovirus infection (infection with human metapneumovirus)
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)

10-19:

  1. Hypoxia (low oxygen in tissues)
  2. Pleural effusion (water on the lungs)
  3. Respiratory distress (difficulty in breathing)
  4. Acute graft versus host disease (acute complication following an allogeneic tissue/blood transplant)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Aspergillosis (an infection caused by a fungus called aspergillus)
  8. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Completed suicide (act of taking one's own life)

20-29:

  1. Electrocardiogram qt prolonged
  2. Flushing (the warm, red condition of human skin)
  3. Hepatic failure (liver failure)
  4. Hepatosplenomegaly (enlargement of both the liver and the spleen)
  5. Hyperbilirubinaemia (excess of bilirubin in the blood)
  6. Hypotension (abnormally low blood pressure)
  7. Infusion related reaction
  8. Multi-organ failure (multisystem organ failure)
  9. Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
  10. Oliguria (not enough urine)

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood alkaline phosphatase increased
  2. Graft versus host disease in lung (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the lung)
  3. Haemophilus infection (bacterial infection by haemophilus influenzae)
  4. Hip arthroplasty
  5. Hyperglycaemia (high blood sugar)
  6. Osteonecrosis (death of bone)
  7. Streptococcal bacteraemia (a bacterial infection of blood)
  8. Transaminases increased

60+:

  1. Aspergillosis (an infection caused by a fungus called aspergillus)
  2. Aspartate aminotransferase increased
  3. Proteinuria (presence of protein in the urine)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Cardiac arrest
  6. Coagulopathy (blood's ability to clot is impaired)
  7. Depressed level of consciousness
  8. Diastolic dysfunction
  9. Drug toxicity
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 27.78%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 27.78%
  3. High Blood Pressure: 5 people, 13.89%
  4. Thrombocytopenia (decrease of platelets in blood): 4 people, 11.11%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 4 people, 11.11%
  6. Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 11.11%
  7. Adenovirus Infection: 3 people, 8.33%
  8. Anaemia (lack of blood): 3 people, 8.33%
  9. Candidiasis (candidiasis or thrush is a fungal infection): 3 people, 8.33%
  10. Electrocardiogram Qt Prolonged: 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clolar and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clolar and Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clolar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clolar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clofarabine and furosemide (the active ingredients of Clolar and Furosemide, respectively), and Clolar and Furosemide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: